TW224943B - The pharmaceutical composition for the stimulation of bone formation - Google Patents

The pharmaceutical composition for the stimulation of bone formation

Info

Publication number
TW224943B
TW224943B TW82102942A TW82102942A TW224943B TW 224943 B TW224943 B TW 224943B TW 82102942 A TW82102942 A TW 82102942A TW 82102942 A TW82102942 A TW 82102942A TW 224943 B TW224943 B TW 224943B
Authority
TW
Taiwan
Prior art keywords
stimulation
bone formation
pharmaceutical composition
bone
abnormality
Prior art date
Application number
TW82102942A
Other languages
Chinese (zh)
Inventor
Ueno Kohji
Katayama Teruaki
Miyamoto Tsumoru
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Priority claimed from JP5121962A external-priority patent/JPH069426A/en
Application granted granted Critical
Publication of TW224943B publication Critical patent/TW224943B/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Use of human interleukin 4 or an analogue thereof in the manufacture of a medicament for the stimulation of bone formation. It is useful for the prevention and treatment of osteoporosis, osteogenesis imperfecta, injured bone and abnormality of dental tissue or teeth and the improvement of metabolic abnormality of bone.
TW82102942A 1993-04-26 1993-04-17 The pharmaceutical composition for the stimulation of bone formation TW224943B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5121962A JPH069426A (en) 1992-04-27 1993-04-26 Osteogenesis promoter

Publications (1)

Publication Number Publication Date
TW224943B true TW224943B (en) 1994-06-11

Family

ID=51348269

Family Applications (1)

Application Number Title Priority Date Filing Date
TW82102942A TW224943B (en) 1993-04-26 1993-04-17 The pharmaceutical composition for the stimulation of bone formation

Country Status (1)

Country Link
TW (1) TW224943B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7622619B2 (en) 2005-07-20 2009-11-24 Lg Display Co., Ltd. Synthesis process

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7622619B2 (en) 2005-07-20 2009-11-24 Lg Display Co., Ltd. Synthesis process

Similar Documents

Publication Publication Date Title
UA29505C2 (en) Pharmaceutical composition for treatment and/or prophylaxis of bone resorption and method of medical treatment and/or prophylaxis of bone resorption in mammals
EP0830138A4 (en) Use of fibroblast growth factors to stimulate bone growth
EP0881908A4 (en) Use of fibroblast growth factors to stimulate bone growth
MX9708800A (en) Bicyclic-aromatic compounds.
HK1029738A1 (en) A combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor.
MX9708803A (en) Diaromatic propynyl or dienyl compounds.
EP0347899A3 (en) Pharmaceutical compositions on egg shell basis and their preparation and use
GR3032041T3 (en) Idebenone compositions for treating Alzheimer's disease.
DE69426530D1 (en) PHARMACEUTICAL COMPOSITION TO PROMOTE TISSUE HEALING AND REGENERATION AND PHARMACEUTICAL SET
Lund et al. Trismus appliances and indications for their use.
IT9019594A0 (en) ORTHOPEDIC IMPLANT PARTICULARLY FOR USE FOR THE REPAIR AND/OR SURGICAL RECONSTRUCTION OF JOINTS OF THE HUMAN BODY
KR930021178A (en) Drugs to stimulate bone formation
TW224943B (en) The pharmaceutical composition for the stimulation of bone formation
MX9800801A (en) Human mp52 arg protein.
DE69424747D1 (en) Pharmaceutical composition for the prevention or treatment of broken bones
UA27230C2 (en) Derivatives of androstane substituted at 16-position with quaternary ammonium group, having neuromuscular blocking effect and pharmaceutical composition having neuromuscular blocking effect
El-Mofty Unilateral loss of the ramus of the mandible
FI953514A (en) A new factor in osteoblast proliferation
HUT60145A (en) Process for producing pharmaceutical composition comprising human interleukin-2 and suitable for treating pneumothorax
IL103499A0 (en) Pharmaceutical compositions for treating anxiety in benzodiazepine withdrawn patients
UA11001C2 (en) Dental implant
BG52004B2 (en) Medicament for the treatment of inflammatory impairments of the alveolar bone and the oral mucous membrane
UA33571A (en) Method for treating traumatic fracture of mandible
UA7956C2 (en) Device for retaining drug on tooth
PT101033A (en) Osseointegrated titanium screw implant